The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 17, 2026
Snapshot (as of Oct 17, 2026): Pfizer Inc. (PFE) pays a $1.72 annual dividend ($0.43 quarterly), yielding 5.84% at $29.58/share. Next ex-dividend date 2026-11-06. 15 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 5.84%
Annual Dividend: $1.72 per share
Payout Ratio: 226.3% (based on depressed trailing earnings — see safety analysis below)
Ex-Dividend Date: 2026-11-06
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 55
Pfizer Inc. is a global biopharmaceutical company founded in 1849, with a portfolio spanning cardiovascular drugs like Eliquis, oncology treatments, vaccines under the Prevnar family, and Paxlovid for COVID-19. The Pfizer Inc. dividend currently yields 6.08%, placing it well above the typical income threshold for healthcare stocks. PFE pays $1.72 per share annually in quarterly installments, with the next ex-dividend date on November 6, 2026. At a beta of 0.276, PFE stock moves far less than the broader market, a characteristic that appeals to income-focused investors who prioritize price stability.
Pfizer Inc. pays out 226.3% of earnings as dividends, a payout ratio classified as high (above 75%) — in fact, it exceeds earnings entirely. The company's broad product base, spanning oncology, vaccines, rare disease treatments, and anti-infectives, generates recurring demand across multiple therapeutic areas, which provides some operational support for the payout. Pfizer Inc. dividend safety is the central question for income investors here: a payout ratio above 200% means the dividend is not covered by current earnings, and any sustained earnings pressure would put the $1.72 annual rate at risk.
Pfizer Inc. dividend history shows a CAGR of 6.0% per year from 2011 to 2025. Per-share payments grew from $0.758 to $1.72 over that period (2026 data is partial and excluded from this calculation). The smallest annual increase in the window was 1.5% in 2016, showing that growth has not always kept pace with inflation.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +2.4% | $1.60 (2022) | $1.72 (2025) |
| 5-Year | +2.5% | $1.52 (2020) | $1.72 (2025) |
| 10-Year | +4.4% | $1.12 (2015) | $1.72 (2025) |
PFE stock fits income-focused investors who want a high (above 4%) yield from a large, diversified biopharmaceutical business. At 6.08%, the current yield sits well above PFE's own 5-year average of 4.76%, which reflects the market pricing in earnings uncertainty rather than a dividend increase. Fifteen consecutive years of dividend increases show a commitment to the payout, but a 226.3% payout ratio is the defining trade-off: income investors get an above-average yield and low price volatility (beta of 0.276), but they accept real earnings-coverage risk in exchange.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-24 | $0.4300 |
| 2026-05-08 | $0.4300 |
| 2026-01-23 | $0.4300 |
| 2025-11-07 | $0.4300 |
| 2025-07-25 | $0.4300 |
| 2025-05-09 | $0.4300 |
| 2025-01-24 | $0.4300 |
| 2024-11-08 | $0.4200 |
| 2024-07-26 | $0.4200 |
| 2024-05-09 | $0.4200 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.2900 |
| 2025 | $1.7200 |
| 2024 | $1.6800 |
| 2023 | $1.6400 |
| 2022 | $1.6000 |
Project income from PFE with the PFE dividend calculator or track your full portfolio with the dividend tracker.